Last 12 months
Inside the activity.
6 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 3 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 3 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 1, 2026 15:57 UTC |
Barry RichardDirector · President & CEO
|
PurchaseCommon Stock | 100,000 | $0.92 | $92,000.00 |
DisclosureSEC source: 0001437749-26-031654 · rdgdoc.xml · nonDerivative · entry 2 Barry Richard · CIK 0001562371 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 1,337,964 F2 · price: The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple open market transactions at prices ranging from $0.91 to $0.93 per share. The reporting person undertakes to provide to Filana, any security holder of Filana or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote. Read SEC document |
| September 29, 2026 Filed Oct 1, 2026 15:57 UTC |
Barry RichardDirector · President & CEO
|
PurchaseCommon Stock | 206,813 | $0.90 | $186,131.70 |
DisclosureSEC source: 0001437749-26-031654 · rdgdoc.xml · nonDerivative · entry 1 Barry Richard · CIK 0001562371 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 1,237,964 F1 · price: The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple open market transactions at prices ranging from $0.86 to $0.94 per share. The reporting person undertakes to provide to Filana, any security holder of Filana or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote. Read SEC document |
| September 28, 2026 Filed Oct 1, 2026 00:03 UTC |
Barry RichardDirector · President & CEO
|
PurchaseCommon Stock | 93,091 | $0.84 | $78,196.44 |
DisclosureSEC source: 0001437749-26-031597 · rdgdoc.xml · nonDerivative · entry 1 Barry Richard · CIK 0001562371 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 1,031,151 F1 · price: The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple open market transactions at prices ranging from $0.82 to $0.85 per share. The reporting person undertakes to provide to Filana, any security holder of Filana or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote. Read SEC document |
| November 24, 2025 Filed Nov 25, 2025 21:06 UTC |
Anderson Robert Eugene JrDirector
|
PurchaseCommon Stock | 8,600 | $2.90 | $24,940.00 |
DisclosureSEC source: 0001437749-25-036321 · rdgdoc.xml · nonDerivative · entry 1 Anderson Robert Eugene Jr · CIK 0002001911 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,600 Read SEC document |
| November 20, 2025 Filed Nov 24, 2025 21:02 UTC |
Barry RichardDirector · President & CEO
|
PurchaseCommon Stock | 150,000 | $2.76 | $414,000.00 |
DisclosureSEC source: 0001437749-25-036125 · rdgdoc.xml · nonDerivative · entry 1 Barry Richard · CIK 0001562371 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 938,060 F1 · price: The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple open market transactions at prices ranging from $2.74 to $2.80 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote. Read SEC document |
| November 19, 2025 Filed Nov 20, 2025 22:39 UTC |
Barry RichardDirector · President & CEO
|
PurchaseCommon Stock | 73,385 | $2.75 | $201,808.75 |
DisclosureSEC source: 0001437749-25-035882 · rdgdoc.xml · nonDerivative · entry 1 Barry Richard · CIK 0001562371 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 788,060 F1 · price: The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple open market transactions at prices ranging from $2.73 to $2.75 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote. Read SEC document |
| October 21, 2025 Filed Oct 22, 2025 22:15 UTC |
Bir Dawn CarterDirector
|
GrantStock Option (Right to Buy) · Derivative | 53,000 | $0.00 Strike: $3.98 | $0.00 |
DisclosureSEC source: 0001437749-25-031540 · rdgdoc.xml · derivative · entry 1 Bir Dawn Carter · CIK 0001688712 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,000 Underlying: Common Stock · 53,000 shares Expires 2035-10-21 F1 · derivative.exercise_date: The stock option vests over three (3) years at a rate of 1/36th each month. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 20:44 UTC |
Cook Robert ChristopherChief Operating & Legal Office
|
PurchaseCommon Stock | 13,725 | $2.91 | $39,939.75 |
DisclosureSEC source: 0001437749-25-030348 · rdgdoc.xml · nonDerivative · entry 1 Cook Robert Christopher · CIK 0001952028 · Chief Operating & Legal Office 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,725 Read SEC document |
| September 22, 2025 Filed Sep 23, 2025 20:06 UTC |
Barry RichardDirector · President & CEO
|
PurchaseCommon Stock | 7,172 | $2.28 | $16,352.16 |
DisclosureSEC source: 0001437749-25-029725 · rdgdoc.xml · nonDerivative · entry 1 Barry Richard · CIK 0001562371 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 714,675 F1 · price: The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple open market transactions at prices ranging from $2.27 to $2.29 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote. Read SEC document |
| September 19, 2025 Filed Sep 22, 2025 20:07 UTC |
Barry RichardDirector · President & CEO
|
PurchaseCommon Stock | 46,908 | $2.29 | $107,419.32 |
DisclosureSEC source: 0001437749-25-029586 · rdgdoc.xml · nonDerivative · entry 4 Barry Richard · CIK 0001562371 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 707,503 Read SEC document |
| September 19, 2025 Filed Sep 22, 2025 20:07 UTC |
Barry RichardDirector · President & CEO
|
PurchaseCommon Stock | 400 | $2.25 | $900.00 |
DisclosureSEC source: 0001437749-25-029586 · rdgdoc.xml · nonDerivative · entry 3 Barry Richard · CIK 0001562371 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 660,595 Read SEC document |
| September 18, 2025 Filed Sep 22, 2025 20:07 UTC |
Barry RichardDirector · President & CEO
|
PurchaseCommon Stock | 185,233 | $2.24 | $414,921.92 |
DisclosureSEC source: 0001437749-25-029586 · rdgdoc.xml · nonDerivative · entry 2 Barry Richard · CIK 0001562371 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 660,195 Read SEC document |
| September 18, 2025 Filed Sep 22, 2025 20:07 UTC |
Barry RichardDirector · President & CEO
|
PurchaseCommon Stock | 5,400 | $2.13 | $11,502.00 |
DisclosureSEC source: 0001437749-25-029586 · rdgdoc.xml · nonDerivative · entry 1 Barry Richard · CIK 0001562371 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 474,962 Read SEC document |
| May 23, 2025 Filed May 27, 2025 20:26 UTC |
Anderson Robert Eugene JrDirector
|
GrantStock Option (Right to Buy) · Derivative | 26,500 | $0.00 Strike: $2.11 | $0.00 |
DisclosureSEC source: 0001437749-25-018505 · rdgdoc.xml · derivative · entry 1 Anderson Robert Eugene Jr · CIK 0002001911 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,500 Underlying: Common Stock · 26,500 shares Expires 2035-05-23 F1 · derivative.exercise_date: Form 4 represents grant pursuant to the Amended Non-employee Director Compensation Program approved by stockholders on May 23, 2025. Stock options vest over a one (1) year period at a rate of 1/12 per month. Read SEC document |
| May 23, 2025 Filed May 27, 2025 20:23 UTC |
Gravier PierreDirector
|
GrantStock Option (Right to Buy) · Derivative | 26,500 | $0.00 Strike: $2.11 | $0.00 |
DisclosureSEC source: 0001437749-25-018503 · rdgdoc.xml · derivative · entry 1 Gravier Pierre · CIK 0001984065 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,500 Underlying: Common Stock · 26,500 shares Expires 2035-05-23 F1 · derivative.exercise_date: Form 4 represents grant pursuant to the Amended Non-employee Director Compensation Program approved by stockholders on May 23, 2025. Stock options vest over a one (1) year period at a rate of 1/12 per month. Read SEC document |
| May 23, 2025 Filed May 27, 2025 20:19 UTC |
Nicaise ClaudeDirector
|
GrantStock Option (Right to Buy) · Derivative | 26,500 | $0.00 Strike: $2.11 | $0.00 |
DisclosureSEC source: 0001437749-25-018497 · rdgdoc.xml · derivative · entry 1 Nicaise Claude · CIK 0001644162 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,500 Underlying: Common Stock · 26,500 shares Expires 2035-05-23 F1 · derivative.exercise_date: Form 4 represents grant pursuant to the Amended Non-employee Director Compensation Program approved by stockholders on May 23, 2025. Stock options vest over a one (1) year period at a rate of 1/12 per month. Read SEC document |
| May 23, 2025 Filed May 27, 2025 20:21 UTC |
GUSSIN ROBERT ZDirector
|
GrantStock Option (Right to Buy) · Derivative | 26,500 | $0.00 Strike: $2.11 | $0.00 |
DisclosureSEC source: 0001437749-25-018500 · rdgdoc.xml · derivative · entry 1 GUSSIN ROBERT Z · CIK 0001245263 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,500 Underlying: Common Stock · 26,500 shares Expires 2035-05-23 F1 · derivative.exercise_date: Form 4 represents grant pursuant to the Amended Non-employee Director Compensation Program approved by stockholders on May 23, 2025. Stock options vest over a one (1) year period at a rate of 1/12 per month. Read SEC document |
| May 23, 2025 Filed May 27, 2025 20:17 UTC |
O DONNELL MICHAEL JDirector
|
GrantStock Option (Right to Buy) · Derivative | 26,500 | $0.00 Strike: $2.11 | $0.00 |
DisclosureSEC source: 0001437749-25-018494 · rdgdoc.xml · derivative · entry 1 O DONNELL MICHAEL J · CIK 0001245266 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,500 Underlying: Common Stock · 26,500 shares Expires 2035-05-23 F1 · derivative.exercise_date: Form 4 represents grant pursuant to the Amended Non-employee Director Compensation Program approved by stockholders on May 23, 2025. Stock options vest over a one (1) year period at a rate of 1/12 per month. Read SEC document |
| May 23, 2025 Filed Jul 16, 2025 20:04 UTC |
SCANNON PATRICK J MD PHDDirector
|
GrantStock Option (Right to Buy) · Derivative | 26,500 | $0.00 Strike: $2.11 | $0.00 |
DisclosureSEC source: 0001437749-25-022829 · rdgdoc.xml · derivative · entry 1 SCANNON PATRICK J MD PHD · CIK 0001222790 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,500 Underlying: Common Stock · 26,500 shares Expires 2035-05-23 F1 · derivative.exercise_date: Form 4 represents grant pursuant to the Amended Non-employee Director Compensation Program approved by stockholders on May 23, 2025. Stock options vest over a one (1) year period at a rate of 1/12 per month. Read SEC document |
| April 17, 2025 Filed Apr 21, 2025 20:51 UTC |
Schoen EricChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.44 | $0.00 |
DisclosureSEC source: 0001437749-25-012557 · rdgdoc.xml · derivative · entry 1 Schoen Eric · CIK 0001532303 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2035-04-17 F1 · derivative.exercise_date: The stock option vests in four equal annual installments (25% each year) with the initial 25% vesting on April 17, 2026. Read SEC document |
| April 17, 2025 Filed Apr 21, 2025 20:45 UTC |
Nassif FredaChief Business Officer
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.44 | $0.00 |
DisclosureSEC source: 0001437749-25-012549 · rdgdoc.xml · derivative · entry 1 Nassif Freda · CIK 0002045036 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2035-04-17 F1 · derivative.exercise_date: The stock option vests in four equal annual installments (25% each year) with the initial 25% vesting on April 17, 2026. Read SEC document |
| April 17, 2025 Filed Apr 21, 2025 20:49 UTC |
Barry RichardDirector · President & CEO
|
GrantStock Option (Right to Buy) · Derivative | 350,000 | $0.00 Strike: $1.44 | $0.00 |
DisclosureSEC source: 0001437749-25-012554 · rdgdoc.xml · derivative · entry 1 Barry Richard · CIK 0001562371 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 350,000 Underlying: Common Stock · 350,000 shares Expires 2035-04-17 F1 · derivative.exercise_date: The stock option vests in four equal annual installments (25% each year) with the initial 25% vesting on April 17, 2026. Read SEC document |
| April 17, 2025 Filed Apr 21, 2025 20:43 UTC |
Cook Robert ChristopherChief Operating & Legal Office
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.44 | $0.00 |
DisclosureSEC source: 0001437749-25-012545 · rdgdoc.xml · derivative · entry 1 Cook Robert Christopher · CIK 0001952028 · Chief Operating & Legal Office 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2035-04-17 F1 · derivative.exercise_date: The stock option vests in four equal annual installments (25% each year) with the initial 25% vesting on April 17, 2026. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 21:18 UTC |
Kupiec James WilliamChief Medical Officer
|
SaleCommon Stock | 4,000 | $3.87 | $15,480.00 |
DisclosureSEC source: 0001437749-24-036551 · rdgdoc.xml · nonDerivative · entry 1 Kupiec James William · CIK 0001839551 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 21:16 UTC |
Schoen EricChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $1.18 | $0.00 |
DisclosureSEC source: 0001437749-24-036546 · rdgdoc.xml · derivative · entry 4 Schoen Eric · CIK 0001532303 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2028-10-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 21:16 UTC |
Schoen EricChief Financial Officer
|
SaleCommon Stock | 59,800 | $3.86 | $230,828.00 |
DisclosureSEC source: 0001437749-24-036546 · rdgdoc.xml · nonDerivative · entry 3 Schoen Eric · CIK 0001532303 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,500 F1 · price: 1. The sale reported in column 4 is a weighted average price. The shares were sold in multiple open market transactions at prices ranging from $3.81 to $3.89 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 21:16 UTC |
Schoen EricChief Financial Officer
|
SaleCommon Stock | 2,000 | $3.82 | $7,640.00 |
DisclosureSEC source: 0001437749-24-036546 · rdgdoc.xml · nonDerivative · entry 2 Schoen Eric · CIK 0001532303 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By limited liability corporation Disclosed balance after: 0 Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 21:16 UTC |
Schoen EricChief Financial Officer
|
Exercise / conversionCommon Stock | 50,000 | $1.18 | $59,000.00 |
DisclosureSEC source: 0001437749-24-036546 · rdgdoc.xml · nonDerivative · entry 1 Schoen Eric · CIK 0001532303 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2024 Filed Nov 20, 2024 21:39 UTC |
Landen JarenChief Clinical Dev. Officer
|
GrantStock Option (Right to Buy) · Derivative | 85,000 | $0.00 Strike: $27.95 | $0.00 |
DisclosureSEC source: 0001437749-24-035872 · rdgdoc.xml · derivative · entry 1 Landen Jaren · CIK 0002045287 · Chief Clinical Dev. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 85,000 shares Expires 2034-11-18 F1 · derivative.exercise_date: The stock option vests in four equal annual installments (25% each year) with the initial 25% vesting on November 18, 2025. Read SEC document |
| November 18, 2024 Filed Nov 20, 2024 21:35 UTC |
Nassif FredaChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $27.95 | $0.00 |
DisclosureSEC source: 0001437749-24-035868 · rdgdoc.xml · derivative · entry 1 Nassif Freda · CIK 0002045036 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2034-11-18 F1 · derivative.exercise_date: The stock option vests in four equal annual installments (25% each year) with the initial 25% vesting on November 18, 2025. Read SEC document |
| October 01, 2024 Filed Oct 1, 2024 20:37 UTC |
Barry RichardDirector · President & CEO
|
GrantStock Option (Right to Buy) · Derivative | 600,000 | $0.00 Strike: $27.42 | $0.00 |
DisclosureSEC source: 0001437749-24-030353 · rdgdoc.xml · derivative · entry 1 Barry Richard · CIK 0001562371 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 600,000 Underlying: Common Stock · 600,000 shares Expires 2034-10-01 F1 · derivative.exercise_date: The stock option vests in four equal annual installments (25% each year) with the initial 25% vesting on July 15, 2025. Read SEC document |
| September 06, 2024 Filed Sep 9, 2024 21:46 UTC |
Schoen EricChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $26.91 | $0.00 |
DisclosureSEC source: 0001437749-24-028784 · rdgdoc.xml · derivative · entry 1 Schoen Eric · CIK 0001532303 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2034-09-06 F1 · derivative.exercise_date: The stock option vests over 2 years, with 50% cliff vesting 1-year after grant date and the remaining 50% cliff vesting 2-years after grant date. Read SEC document |
| September 06, 2024 Filed Sep 9, 2024 21:43 UTC |
Cook Robert ChristopherSVP & General Counsel
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $26.91 | $0.00 |
DisclosureSEC source: 0001437749-24-028782 · rdgdoc.xml · derivative · entry 1 Cook Robert Christopher · CIK 0001952028 · SVP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2034-09-06 F1 · derivative.exercise_date: The stock option vests over 2 years, with 50% cliff vesting 1-year after grant date and the remaining 50% cliff vesting 2-years after grant date. Read SEC document |
| September 06, 2024 Filed Sep 9, 2024 21:41 UTC |
Kupiec James WilliamChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $26.91 | $0.00 |
DisclosureSEC source: 0001437749-24-028780 · rdgdoc.xml · derivative · entry 1 Kupiec James William · CIK 0001839551 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2034-09-06 F1 · derivative.exercise_date: The stock option vests over 2 years, with 50% cliff vesting 1-year after grant date and the remaining 50% cliff vesting 2-years after grant date. Read SEC document |
| May 20, 2024 Filed May 22, 2024 20:54 UTC |
BARBIER REMIDirector · President & CEO
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $22.10 | $0.00 |
DisclosureSEC source: 0001437749-24-018027 · rdgdoc.xml · derivative · entry 1 BARBIER REMI · CIK 0001133806 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2034-05-20 F1 · derivative.exercise_date: The stock option vests over four (4) years at a rate of 1/48th each full month. Read SEC document |
| May 20, 2024 Filed May 22, 2024 20:52 UTC |
Cook Robert ChristopherSVP & General Counsel
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $22.10 | $0.00 |
DisclosureSEC source: 0001437749-24-018023 · rdgdoc.xml · derivative · entry 1 Cook Robert Christopher · CIK 0001952028 · SVP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2034-05-20 F1 · derivative.exercise_date: The stock option vests over four (4) years at a rate of 1/48th each full month. Read SEC document |
| May 20, 2024 Filed May 22, 2024 20:53 UTC |
Schoen EricChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $22.10 | $0.00 |
DisclosureSEC source: 0001437749-24-018024 · rdgdoc.xml · derivative · entry 1 Schoen Eric · CIK 0001532303 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2034-05-20 F1 · derivative.exercise_date: The stock option vests over four (4) years at a rate of 1/48th each full month. Read SEC document |
| May 20, 2024 Filed May 22, 2024 20:51 UTC |
Kupiec James WilliamChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $22.10 | $0.00 |
DisclosureSEC source: 0001437749-24-018022 · rdgdoc.xml · derivative · entry 1 Kupiec James William · CIK 0001839551 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2034-05-20 F1 · derivative.exercise_date: The stock option vests over four (4) years at a rate of 1/48th each full month. Read SEC document |
| May 16, 2024 Filed May 16, 2024 23:13 UTC |
ROBERTSON SANFORDDirector
|
GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-017355 · rdgdoc.xml · nonDerivative · entry 2 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By spouse Disclosed balance after: 5,000 Read SEC document |
| May 16, 2024 Filed May 16, 2024 23:13 UTC |
ROBERTSON SANFORDDirector
|
GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-017355 · rdgdoc.xml · nonDerivative · entry 1 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 950,851 Read SEC document |
| May 09, 2024 Filed May 13, 2024 20:19 UTC |
GUSSIN ROBERT ZDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $21.11 | $0.00 |
DisclosureSEC source: 0001437749-24-016251 · rdgdoc.xml · derivative · entry 1 GUSSIN ROBERT Z · CIK 0001245263 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2034-05-09 F1 · derivative.exercise_date: Form 4 represents grant pursuant to the Non-employee Director Compensation Program approved by stockholders on May 4, 2023. Stock options vest over a one (1) year period at a rate of 1/12 per month. Read SEC document |
| May 09, 2024 Filed May 13, 2024 20:19 UTC |
O DONNELL MICHAEL JDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $21.11 | $0.00 |
DisclosureSEC source: 0001437749-24-016250 · rdgdoc.xml · derivative · entry 1 O DONNELL MICHAEL J · CIK 0001245266 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2034-05-09 F1 · derivative.exercise_date: Form 4 represents grant pursuant to the Non-employee Director Compensation Program approved by stockholders on May 4, 2023. Stock options vest over a one (1) year period at a rate of 1/12 per month. Read SEC document |
| May 09, 2024 Filed May 13, 2024 20:17 UTC |
Barry RichardDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $21.11 | $0.00 |
DisclosureSEC source: 0001437749-24-016247 · rdgdoc.xml · derivative · entry 1 Barry Richard · CIK 0001562371 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2034-05-09 F1 · derivative.exercise_date: Form 4 represents grant pursuant to the Non-employee Director Compensation Program approved by stockholders on May 4, 2023. Stock options vest over a one (1) year period at a rate of 1/12 per month. Read SEC document |
| May 09, 2024 Filed May 13, 2024 20:15 UTC |
ROBERTSON SANFORDDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $21.11 | $0.00 |
DisclosureSEC source: 0001437749-24-016243 · rdgdoc.xml · derivative · entry 1 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2034-05-09 F1 · derivative.exercise_date: Form 4 represents grant pursuant to the Non-employee Director Compensation Program approved by stockholders on May 4, 2023. Stock options vest over a one (1) year period at a rate of 1/12 per month. Read SEC document |
| May 09, 2024 Filed May 13, 2024 20:14 UTC |
SCANNON PATRICK J MD PHDDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $21.11 | $0.00 |
DisclosureSEC source: 0001437749-24-016242 · rdgdoc.xml · derivative · entry 1 SCANNON PATRICK J MD PHD · CIK 0001222790 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2034-05-09 F1 · derivative.exercise_date: Form 4 represents grant pursuant to the Non-employee Director Compensation Program approved by stockholders on May 4, 2023. Stock options vest over a one (1) year period at a rate of 1/12 per month. Read SEC document |
| May 09, 2024 Filed May 13, 2024 20:13 UTC |
Anderson Robert Eugene JrDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $21.11 | $0.00 |
DisclosureSEC source: 0001437749-24-016241 · rdgdoc.xml · derivative · entry 1 Anderson Robert Eugene Jr · CIK 0002001911 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2034-05-09 F1 · derivative.exercise_date: Form 4 represents grant pursuant to the Non-employee Director Compensation Program approved by stockholders on May 4, 2023. Stock options vest over a one (1) year period at a rate of 1/12 per month. Read SEC document |
| May 09, 2024 Filed May 13, 2024 20:11 UTC |
Gravier PierreDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $21.11 | $0.00 |
DisclosureSEC source: 0001437749-24-016237 · rdgdoc.xml · derivative · entry 1 Gravier Pierre · CIK 0001984065 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2034-05-09 F1 · derivative.exercise_date: Form 4 represents grant pursuant to the Non-employee Director Compensation Program approved by stockholders on May 4, 2023. Stock options vest over a one (1) year period at a rate of 1/12 per month. Read SEC document |
| May 09, 2024 Filed May 13, 2024 20:05 UTC |
Nicaise ClaudeDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $21.11 | $0.00 |
DisclosureSEC source: 0001437749-24-016227 · rdgdoc.xml · derivative · entry 1 Nicaise Claude · CIK 0001644162 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2034-05-09 F1 · derivative.exercise_date: Form 4 represents grant pursuant to the Non-employee Director Compensation Program approved by stockholders on May 4, 2023. Stock options vest over a one (1) year period at a rate of 1/12 per month. Read SEC document |
| April 26, 2024 Filed Apr 30, 2024 13:13 UTC |
ROBERTSON SANFORDDirector
|
Exercise / conversionCommon Stock Warrant · Derivative | 46,000 | $0.00 Strike: $33.00 | $0.00 |
DisclosureSEC source: 0001437749-24-013866 · rdgdoc.xml · derivative · entry 5 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 308,740 Underlying: Common Stock · 69,000 shares Expires 2024-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Form 4 represents exercise of common stock warrants received on January 3, 2024 for cash. Holder received one and one-half shares of common stock for each common stock warrant exercised. Read SEC document |
| April 26, 2024 Filed Apr 30, 2024 13:13 UTC |
ROBERTSON SANFORDDirector
|
Exercise / conversionCommon Stock | 69,000 | $22.00 | $1,518,000.00 |
DisclosureSEC source: 0001437749-24-013866 · rdgdoc.xml · nonDerivative · entry 1 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 955,851 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Form 4 represents exercise of common stock warrants received on January 3, 2024 for cash. Holder received one and one-half shares of common stock for each common stock warrant exercised. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.